Heart Surgery
FDA: Class I recall of LivaNova’s LifeSPARC System
Editor's Note The Food and Drug Administration (FDA) on September 30 identified the recall by LivaNova (TandemLife) of its LifeSPARC System, Model LS-1000, as Class I, the most serious. The recall was initiated because of the risk of unintentional extended pump stop during Controller Critical Failure mode, caused by a…
FDA: Class I recall of Medtronic’s HeartWare HVAD system batteries
Editor's Note The Food and Drug Administration on August 25 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system batteries as Class I, the most serious. Medtronic is recalling the batteries because they may experience electrical faults that cause them to unexpectedly fail. A similar recall…
FDA: Class I recall of Medtronic’s HVAD batteries
Editor's Note The Food and Drug Administration (FDA), on June 23, identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) batteries as Class I, the most serious. The recall for a single lot (Model Number:1650DE) of HVAD batteries was initiated because of welding defects that allow separation…
FDA: Class I recall of Medtronic HVAD Pump Implant Kit
Editor's Note The Food and Drug Administration (FDA) on June 8 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit as Class I, the most serious. The HVAD System is used as a bridge to cardiac transplants. The Kit was recalled because of a…
Collateral damage of COVID-19 on CV services
Editor's Note This systematic review and meta-analysis led by researchers in the UK finds that across the world, cardiovascular (CV) services were severely disrupted, and as a result cardiac disease is expected to worsen, and repercussions will be felt for years to come. This analysis spans 2 years (2020 to…
UW Medicine conducting national clinical trial on inflatable tubular stent
Editor's Note Cardiologists at the University of Washington School of Medicine (UW Medicine) in Seattle, Washington, are participating in a national clinical trial to test a device designed to control bleeding if a vessel near the heart is inadvertently perforated during a catheter-based procedure, Healthcare Purchasing News May 26 reported.…
The Joint Commission, AHA launch Comprehensive Heart Attack Center certification program
Editor's Note The Joint Commission and the American Heart Association, on April 20, announced the launch of a Comprehensive Heart Attack Center certification program, which recognizes hospitals providing care to the most complex and critically ill patients. To be certified, hospitals must provide 24-hours-a-day, 7-days-a-week on-site coverage for primary percutaneous…
Key items for cardiovascular, peripheral vascular service lines
Ambulatory surgery centers (ASCs) are ramping up cardiovascular and peripheral vascular service lines, as Medicare offers payment for a growing number of cardiac procedures and accrediting bodies offer support for this methodology. In 2021, the Medicare Payment Advisory Commission reported that the number of ASCs billing Medicare for cardiology procedures…
A systemic approach to cardiac service line safety
Among Surgical Care Affiliates’ (SCA) 260-plus facilities in the US, at least 10% have added cardiovascular/peripheral vascular service capabilities. SCA experts anticipate more growth in this area. However, any successful launch starts with an organizational focus on patient safety, says Ezra Erb, vice president for clinical quality at SCA, which…
Report: Cardiology is fastest growing ASC specialty
Editor's Note According to the 2022 Key ASC Benchmarks and Industry Figures report published by Avanza Healthcare Strategies, an ASC consulting firm, cardiology is the fastest growing ASC specialty, Becker’s ASC Review March 10 reports. The Avanza report was released on March 8 and is a “compilation of recently [as…
Free Daily News
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO
- CMS final rule for CY 2025: Key updates impacting Medicare payments, quality programs
- GAO urges HHS to strengthen cybersecurity oversight
- Study: GLP-1s reduce TKA complications for non-diabetic patients with obesity